Loading clinical trials...
Loading clinical trials...
Multicenter randomized double blind study versus placebo during 12 weeks with at first, an escalating dose period followed by stable dose period at the selected dose. This double-blind period can be ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bioprojet
NCT05939453 · Prader-Willi Syndrome, Excessive Daytime Sleepiness, and more
NCT07376343 · OSA - Obstructive Sleep Apnea
NCT07387094 · OSA - Obstructive Sleep Apnea, Obesity
NCT06722755 · Stroke Patients, CPAP, and more
NCT07113288 · Obstructive Sleep Apnea (OSA)
CHU Grenoble
Grenoble
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions